NCT00407524View on ClinicalTrials.gov

AKL 1 Asthma Study

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

March 31, 2005

Conditions
Asthma
Interventions
DRUG

AKL 1

Trial Locations (1)

AB25 2AY

ACCRU, Aberdeen

All Listed Sponsors
lead

University of Aberdeen

OTHER

NCT00407524 - AKL 1 Asthma Study | Biotech Hunter | Biotech Hunter